What is abciximab used for?
Abciximab is used to help prevent blood clots in certain high-risk heart conditions. It is given around the time of procedures such as percutaneous coronary intervention (PCI, including angioplasty and stent placement) to reduce the risk of a heart attack caused by clotting in the treated artery.
How is abciximab used during PCI (angioplasty/stenting)?
In practice, it’s typically used as an intravenous medicine in the catheterization setting, as part of “antiplatelet” therapy around PCI. Its role is to block platelet activation so platelets are less likely to clump and form a clot at the procedure site.
Who might be prescribed abciximab?
It’s generally reserved for people considered higher risk for clot-related complications during PCI. The exact patient selection depends on the clinical scenario and the overall antiplatelet/anticoagulant plan used by the treating team.
What is abciximab doing in the body?
Abciximab works by inhibiting platelet aggregation through blockade of platelet receptors involved in activation and clot formation. This helps lower the chance of thrombus (clot) development during and after the coronary intervention.
What conditions are linked to its use?
The main clinical use is in the setting of coronary artery disease requiring PCI, where clot prevention is important to reduce the risk of ischemic events such as myocardial infarction.
Are there alternatives to abciximab?
Other antiplatelet drugs and agents used around PCI may be used instead depending on availability, patient factors, and local clinical protocols. Choice depends on the clinician’s assessment of risk and the specific procedure context.
Sources
I can answer more precisely (including the exact approved indication wording) if you share what you mean by “uses” (e.g., “for what diseases,” “for what procedure,” or “what conditions it treats”) and the country/label you’re using.